Women's Health Policy

ABORTION IN THE U.S.

Abortion on the 2026 Ballot: The Evolving Landscape of State Abortion Initiatives 

Since the Supreme Court’s Dobbs decision, overturning Roe v. Wade, voters in 17 states have weighed in on ballot measures regarding abortion — some more than once. In November 2026, voters in Idaho, Missouri, Nevada, and Virginia will weigh in on abortion measures that could change the legal status of abortion in their state. In addition, a measure in Colorado is in the process of collecting signatures.

CONTRACEPTIve care IN THE U.S.

SELECTED RESOURCES

featured

Women's Health Survey

The Women’s Health Survey is a series of nationally representative surveys on women’s health conducted by KFF since 2001. The survey aims to track and document women’s experiences with the health care system, access challenges and barriers to care, knowledge related to health and well-being, and differences between women by age, race/ethnicity, income level, and insurance type.

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Womens Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials
  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.
  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.
  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.
  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.
  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Stay informed.

Stay informed.

Filter

231-240 of 882 results

  • Will Insurance Cover Over-the-Counter Contraceptive Pills? A Discussion of Coverage Options and Challenges

    Event Date:
    Event

    The U.S. Food and Drug Administration recently approved Opill—the first over-the-counter daily oral contraceptive pill in the United States. Beginning in early 2024, people will be able to purchase Opill without a prescription, expanding options for contraceptive access across the country. On September 15, 2023, a panel of experts joined Laurie Sobel, associate director for KFF’s Women’s Health Policy program, to explore approaches to covering over-the-counter oral contraception without a prescription. The panel discussed lessons…

  • Large Shares of Black Adults, Hispanic Adults, and Rural Residents are Unsure Whether to Believe Many False Health Claims  

    News Release

    Drawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities. As with the general public, large shares within each group are uncertain about whether each of 10 false health claims are true or not, describing them as either “probably true” or “probably false.” This uncertainty leaves people vulnerable to misinformation but also provides an opportunity to combat…

  • KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year 

    News Release

    As Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it. Based on interviews with nearly 80 representatives from private insurance plans, state Medicaid programs, chain pharmacies, and other key groups, the report provides a deeper view into the operational challenges in expanding access to…

  • Insurance Coverage of OTC Oral Contraceptives: Lessons from the Field

    Report

    This report is based on 35 structured interviews conducted from January to August 2023, with nearly 80 experts and key players such as pharmacists, health plans, and state Medicaid officials involved in the coverage and provision of OTC contraception in seven states with one or more of these coverage approaches (IL, NJ, NM, NY, OR, UT, and WA). It discusses the challenges and successes in coverage under private health insurance and Medicaid and reviews policy…

  • KFF Health Misinformation Tracking Poll Pilot

    Poll Finding

    The poll reveals that at least four in ten U.S. adults saying they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. While relatively small shares definitely believes the false claims, many more are uncertain about them. The survey also examines the public’s social and traditional media use and trust in sources of health information.

  • Poll: Most Americans Encounter Health Misinformation, and Most Aren’t Sure Whether It’s True or False 

    News Release

    A new KFF survey reveals the broad reach of health misinformation, with at least four in 10 people saying that they’ve heard each of 10 specific false claims about COVID-19, reproductive health, and gun violence. Relatively small shares say that each of those false claims are “definitely true”, ranging from as few as 3% who definitively believe that COVID-19 vaccines have been proven to cause infertility to as many as 18% who definitively believe armed…

  • Health Care Issues in the Early Stages of the 2024 Election

    Perspective

    In this JAMA Health Forum column, Larry Levitt examines differences in the Republican presidential candidates’ records and positions on health issues, including Medicaid and abortion, that could play a role in the primaries and would set up a sharp contrast in the general election against President Biden.